When Pills Are Not an Option: Procedural Pathways in a Case of Drug-Intolerant Resistant Hypertension

Introduction: Resistant hypertension is a complex clinical condition typically managed with combination pharmacotherapy. However, treatment becomes exceptionally challenging when standard antihypertensives are poorly tolerated. We report a unique case of a 79-year-old female with longstanding, poorly controlled hypertension who was intolerant to over 60 medications, including nearly every class of antihypertensives. Case Description: The patient presented with flash pulmonary edema and hypertensive emergency, requiring ICU admission. Her blood pressure on arrival exceeded 250 mmHg systolic. She had a 20-year history of uncontrolled hypertension and was labeled allergic to 61 medications.Only clonidine and propranolol were tolerated, offering limited control. Past imaging revealed 60% right renal artery stenosis. Despite her previous refusal of procedural interventions and multiple discharges against medical advice, she consented to care following this life-threatening episode. Laboratory studies showed AKI (Cr 1.3), troponin 1,500, BNP 500 (peaking at 2,000), and early sepsis markers. Workup for secondary causes of hypertension, including pheochromocytoma and coarctation, was negative. Bilateral renal artery stenting was performed without significant improvement in BP, The patient remained mostly asymptomatic post-stenting and was referred for renal denervation. Discussion: This case underscores the clinical dilemma of managing resistant hypertension in the context of extreme drug intolerance. Although some labeled allergies were later validated, others likely represented side effects misclassified as true allergies, emphasizing the need for cautious rechallenge strategies under supervision. Despite initial invasive intervention, BP remained unstable, warranting consideration of renal denervation. Emerging trials (e.g., SPYRAL HTN-OFF MED) suggest its utility in cases unresponsive to medications. This patient’s eventual procedural acceptance following acute deterioration highlights how crisis events can pivot patient behavior. Clinicians must remain flexible, recognizing that symptom burden does not always reflect hemodynamic severity, and that multidisciplinary, patient-centered approaches are vital in extreme presentations of resistant hypertension.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025sj5f93f7
Primary Topic
Renal and Vascular Pathologies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

When Pills Are Not an Option: Procedural Pathways in a Case of Drug-Intolerant Resistant Hypertension

Nabeel Siddiqui, ABDELRAHMAN SHEHATA, Puneet Chhabra, Roger Lin et al.
Journal of the American Society of Nephrology
Renal and Vascular Pathologies
article

When Pills Are Not an Option: Procedural Pathways in a Case of Drug-Intolerant Resistant Hypertension

Nabeel Siddiqui, ABDELRAHMAN SHEHATA, Puneet Chhabra, Roger Lin, Mohamad Khedari
article en

Abstract

Introduction: Resistant hypertension is a complex clinical condition typically managed with combination pharmacotherapy. However, treatment becomes exceptionally challenging when standard antihypertensives are poorly tolerated. We report a unique case of a 79-year-old female with longstanding, poorly controlled hypertension who was intolerant to over 60 medications, including nearly every class of antihypertensives. Case Description: The patient presented with flash pulmonary edema and hypertensive emergency, requiring ICU admission. Her blood pressure on arrival exceeded 250 mmHg systolic. She had a 20-year history of uncontrolled hypertension and was labeled allergic to 61 medications.Only clonidine and propranolol were tolerated, offering limited control. Past imaging revealed 60% right renal artery stenosis. Despite her previous refusal of procedural interventions and multiple discharges against medical advice, she consented to care following this life-threatening episode. Laboratory studies showed AKI (Cr 1.3), troponin 1,500, BNP 500 (peaking at 2,000), and early sepsis markers. Workup for secondary causes of hypertension, including pheochromocytoma and coarctation, was negative. Bilateral renal artery stenting was performed without significant improvement in BP, The patient remained mostly asymptomatic post-stenting and was referred for renal denervation. Discussion: This case underscores the clinical dilemma of managing resistant hypertension in the context of extreme drug intolerance. Although some labeled allergies were later validated, others likely represented side effects misclassified as true allergies, emphasizing the need for cautious rechallenge strategies under supervision. Despite initial invasive intervention, BP remained unstable, warranting consideration of renal denervation. Emerging trials (e.g., SPYRAL HTN-OFF MED) suggest its utility in cases unresponsive to medications. This patient’s eventual procedural acceptance following acute deterioration highlights how crisis events can pivot patient behavior. Clinicians must remain flexible, recognizing that symptom burden does not always reflect hemodynamic severity, and that multidisciplinary, patient-centered approaches are vital in extreme presentations of resistant hypertension.

Journal of the American Society of NephrologyVol. 36(10S)
Southeast Health District (US)
Openalex Percentile: Top 44%
Renal and Vascular Pathologies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.